Cotinine: pharmacologically active metabolite of nicotine and neural mechanisms for its actions

X Tan, K Vrana, ZM Ding - Frontiers in Behavioral Neuroscience, 2021 - frontiersin.org
Tobacco use disorder continues to be a leading public health issue and cause of premature
death in the United States. Nicotine is considered as the major tobacco alkaloid causing …

Vascular depression consensus report–a critical update

HJ Aizenstein, A Baskys, M Boldrini, MA Butters… - BMC medicine, 2016 - Springer
Background Vascular depression is regarded as a subtype of late-life depression
characterized by a distinct clinical presentation and an association with cerebrovascular …

Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases

V Echeverria, C Mendoza, A Iarkov - Frontiers in Neuroscience, 2023 - frontiersin.org
Animal survival depends on cognitive abilities such as learning and memory to adapt to
environmental changes. Memory functions require an enhanced activity and connectivity of …

Strategies for the treatment of Parkinson's disease: beyond dopamine

A Iarkov, GE Barreto, JA Grizzell… - Frontiers in aging …, 2020 - frontiersin.org
Parkinson's disease (PD) is the second-leading cause of dementia and is characterized by a
progressive loss of dopaminergic neurons in the substantia nigra alongside the presence of …

Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?

V Echeverria, G E. Barreto… - Current Alzheimer …, 2017 - benthamdirect.com
Background: The vascular endothelial growth factor (VEGF) is a neuroprotective cytokine
that promotes neurogenesis and angiogenesis in the brain. In animal models, it has been …

A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia

MM Conti, N Chambers, C Bishop - Neuroscience & Biobehavioral …, 2018 - Elsevier
Traditionally, dopamine (DA) and acetylcholine (ACh) striatal systems were considered
antagonistic and imbalances or aberrant signaling between these neurotransmitter systems …

Ultrasound of alternating frequencies and variable emotional impact evokes depressive syndrome in mice and rats

A Morozova, E Zubkov, T Strekalova… - Progress in Neuro …, 2016 - Elsevier
Emotional stress is primarily triggered by the cognitive processing of negative input; it is
regarded as a serious pathogenetic factor of depression that is challenging to model in …

Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders

AV Terry Jr, PM Callahan, CM Hernandez - Biochemical pharmacology, 2015 - Elsevier
The challenges associated with develo** more effective treatments for neurologic and
psychiatric illness such as Alzheimer's disease and schizophrenia are considerable. Both …

Molecular insights into memory-enhancing metabolites of nicotine in brain: a systematic review

A Majdi, F Kamari, S Sadigh-Eteghad… - Frontiers in …, 2019 - frontiersin.org
Background: The alleged procognitive effects of nicotine and its metabolites in brain are
controversial. Objective: Here, we review the pharmacologically active metabolites of …

Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats

A Iarkov, D Appunn, V Echeverria - Cancer chemotherapy and …, 2016 - Springer
Purpose Most cancer patients treated with systemic adjuvant chemotherapy endure long-
lasting side effects including decrease in concentration, forgetfulness and slower thinking …